Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 19, 2010

Premium

Arrowhead Research, the parent company of Calando Pharmaceuticals and minority owner of Leonardo Biosystems, has appointed Mauro Ferrari to its board of directors.

Ferrari is currently Arrowhead's scientific advisory chairman, a position he will resign when he joins the board. He is also a professor of experimental therapeutics at the University of Texas MD Anderson Cancer Center and a professor of bioengineering at Rice University.

Ferrari, a co-founder of Leonardo, was recently named president and CEO of The Methodist Hospital Research Institute in Houston.